- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-MPO
MPO Monoclonal Antibody for IF, IHC, WB, ELISA
Hôte / Isotype
Mouse / IgA
Réactivité testée
Humain, rat et plus (2)
Applications
WB, IP, IHC, IF, ELISA
Conjugaison
Non conjugué
CloneNo.
4C11F6
N° de cat : 66177-1-Ig
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules HL-60, |
Résultats positifs en IHC | tissu hépatique humain, tissu d'amygdalite humain il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
Résultats positifs en IF | tissu d'amygdalite humain, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:1000-1:8000 |
Immunohistochimie (IHC) | IHC : 1:400-1:1600 |
Immunofluorescence (IF) | IF : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 1 publications below |
WB | See 6 publications below |
IHC | See 14 publications below |
IF | See 20 publications below |
IP | See 1 publications below |
Informations sur le produit
66177-1-Ig cible MPO dans les applications de WB, IP, IHC, IF, ELISA et montre une réactivité avec des échantillons Humain, rat
Réactivité | Humain, rat |
Réactivité citée | rat, bovin, Humain, Vache |
Hôte / Isotype | Mouse / IgA |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | MPO Protéine recombinante Ag17564 |
Nom complet | myeloperoxidase |
Masse moléculaire calculée | 745 aa, 84 kDa |
Poids moléculaire observé | 90 kDa |
Numéro d’acquisition GenBank | BC130476 |
Symbole du gène | MPO |
Identification du gène (NCBI) | 4353 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Précipitation de l'acide caprylique/du sulfate d'ammonium |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
The MPO gene encodes myeloperoxidase, a lysosomal hemoprotein located in the azurophilic granules of polymorphonuclear (PMN) leukocytes and monocytes. In response to stimulation, MPO is activated into a transient intermediate with potent antimicrobial oxidizing abilities(PMID:17650507). The mRNA is translated into a single protein of 90 kDa, which displays enzymatic activity and undergoes proteolytic maturation into a heavy chain of 59 kDa and a light chain of 13.5 kDa; these subunits then dimerize into the mature tetramer and the mature MPO is a heterotetramer composed of two identical heavy chains and two identical light chains(PMID:12773517). Fragments with molecular masses of 43-47 kDa were formed by autocatalysis during warming in sample buffer (PMID:12960244). The 24-kDa material had a map identical to that of 13.5 kDa subunit and represents a dimer of the 13.5 kDa subunit (PMID:3008892). Defects in MPO are the cause of myeloperoxidase deficiency (MPOD). It has 3 isoforms produced by alternative splicing.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for MPO antibody 66177-1-Ig | Download protocol |
IHC protocol for MPO antibody 66177-1-Ig | Download protocol |
IF protocol for MPO antibody 66177-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
PLoS Pathog Prion protein signaling induces M2 macrophage polarization and protects from lethal influenza infection in mice. | ||
Sci Rep Persisting and Increasing Neutrophil Infiltration Associates with Gastric Carcinogenesis and E-cadherin Downregulation. | ||
Sci Rep Interleukin 22 attenuated angiotensin II induced acute lung injury through inhibiting the apoptosis of pulmonary microvascular endothelial cells. | ||
Front Immunol Leukocytes in Cerebral Thrombus Respond to Large-Vessel Occlusion in a Time-Dependent Manner and the Association of NETs With Collateral Flow. | ||
Front Immunol An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration | ||
Front Oncol Stromal Neutrophil Extracellular Trap Density Is an Independent Prognostic Factor for Cervical Cancer Recurrence. |